Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.35B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$556M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$488M |
| 5 |
Coca-Cola
KO
|
+$464M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.15B |
| 3 |
Microsoft
MSFT
|
+$777M |
| 4 |
McDonald's
MCD
|
+$585M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$549M |
Sector Composition
| 1 | Technology | 16.54% |
| 2 | Healthcare | 16.17% |
| 3 | Consumer Discretionary | 11.83% |
| 4 | Financials | 10.91% |
| 5 | Industrials | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2276
VistaGen Therapeutics
VTGN
$91.4M
| $2.19M | ﹤0.01% |
629,645
-114,275
| -15% | -$398K |
|
2277
NatWest
NWG
$55.8B
| $2.19M | ﹤0.01% |
272,606
-41,903
| -13% | -$336K |
|
2278
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.19B
| $2.19M | ﹤0.01% |
24,804
+22,729
| +1,095% | +$2M |
|
2279
Covenant Logistics
CVLG
$555M
| $2.18M | ﹤0.01% |
88,540
-34,884
| -28% | -$860K |
|
|
TRTX
2280
TPG RE Finance Trust
TRTX
$726M
| $2.18M | ﹤0.01% |
252,273
-295,237
| -54% | -$2.55M |
|
2281
Pampa Energía
PAM
$3.12B
| $2.18M | ﹤0.01% |
49,176
-3,228
| -6% | -$143K |
|
2282
Vicor
VICR
$2.38B
| $2.18M | ﹤0.01% |
65,615
-30,928
| -32% | -$1.03M |
|
2283
Centrus Energy
LEU
$5.36B
| $2.17M | ﹤0.01% |
50,852
+10,249
| +25% | +$438K |
|
2284
Ranpak Holdings
PACK
$427M
| $2.17M | ﹤0.01% |
338,045
+305,380
| +935% | +$1.96M |
|
2285
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
$2.6B
| $2.16M | ﹤0.01% |
56,745
+26,822
| +90% | +$1.02M |
|
2286
iShares Bitcoin Trust
IBIT
$86.8B
| $2.16M | ﹤0.01% |
63,186
-377,523
| -86% | -$12.9M |
|
2287
ProShares Short VIX Short-Term Futures ETF
SVXY
$253M
| $2.16M | ﹤0.01% |
35,121
-392,863
| -92% | -$24.1M |
|
2288
Avantis US Equity ETF
AVUS
$9.73B
| $2.14M | ﹤0.01% |
23,772
+12,423
| +109% | +$1.12M |
|
2289
Mesa Laboratories
MLAB
$402M
| $2.14M | ﹤0.01% |
24,695
-9,085
| -27% | -$788K |
|
2290
Franklin FTSE Europe ETF
FLEE
$118M
| $2.14M | ﹤0.01% |
73,813
-34,043
| -32% | -$988K |
|
|
OMGA
2291
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $2.14M | ﹤0.01% |
1,033,135
+1,009,635
| +4,296% | +$2.09M |
|
2292
Intapp
INTA
$3.66B
| $2.14M | ﹤0.01% |
58,272
+58,264
| +728,300% | +$2.14M |
|
2293
Encore Capital Group
ECPG
$1.04B
| $2.14M | ﹤0.01% |
51,182
-8,783
| -15% | -$367K |
|
2294
Cirrus Logic
CRUS
$6.17B
| $2.13M | ﹤0.01% |
16,714
-55,844
| -77% | -$7.13M |
|
2295
iShares MSCI Emerging Markets ex China ETF
EMXC
$13.3B
| $2.13M | ﹤0.01% |
36,027
-10,098
| -22% | -$598K |
|
2296
Navitas Semiconductor
NVTS
$1.49B
| $2.13M | ﹤0.01% |
542,532
+107,688
| +25% | +$423K |
|
2297
Skye Bioscience
SKYE
$124M
| $2.13M | ﹤0.01% |
+265,587
| New | +$2.13M |
|
2298
First Trust Consumer Staples AlphaDEX Fund
FXG
$276M
| $2.12M | ﹤0.01% |
32,944
+18,433
| +127% | +$1.19M |
|
2299
WisdomTree International Multifactor Fund
DWMF
$41.5M
| $2.12M | ﹤0.01% |
81,065
+39,528
| +95% | +$1.03M |
|
2300
Genesco
GCO
$358M
| $2.12M | ﹤0.01% |
81,907
+52,107
| +175% | +$1.35M |
|